1-9 of 9
sertraline
Close
Sort by
Journal Articles

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

Rafee Talukder, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1438.
https://doi.org/10.1182/blood-2019-131581
Published: 2019
Journal Articles

The Impact of Depression and Use of Anti-Depressants on Healthcare Resource Utilization (HCRU) in Multiple Myeloma (MM) Patients

Jessica Chung, PhD MPH, Damion Nero, PhD, Bruce Feinberg, DO, Jonathan Kish, PhD MPH, Chadi Nabhan, MD MBA, FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 3449.
https://doi.org/10.1182/blood.V130.Suppl_1.3449.3449
Published: 2017
Journal Articles

Phase 2 Study of Pracinostat in Combination with Ruxolitinib in Patients (pts) with Myelofibrosis (MF)

Prithviraj Bose, MD, Naveen Pemmaraju, MD, Kurt Schroeder, Alessandra Ferrajoli, MD, Elias J. Jabbour, MD, Naval Daver, MD, Courtney D. DiNardo, MDMSc, Yesid Alvarado, MD, Musa Yilmaz, MD, Julie Huynh-Lu, Physician Assistant, Wei Qiao, PhD, Xuemei Wang, Aurelio Matamoros, Lingsha Zhou, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1632.
https://doi.org/10.1182/blood.V130.Suppl_1.1632.1632
Published: 2017
Journal Articles

Anti-Depressant Use in Patients with Multiple Myeloma Less Common Than Expected

Hui Hui Li, MD, Nita Williams, Nidhi Sharma, PhD, Yvonne A Efebera, MD MPH, Ashley E Rosko, MD, Don M Benson, MD PhD, Craig C Hofmeister
Journal: Blood
Blood (2016) 128 (22): 2420.
https://doi.org/10.1182/blood.V128.22.2420.2420
Published: 2016
Journal Articles

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Gabriela Sanchez, MD, Ang Li, MD, Sarvari Venkata Yellapragada, MD, Martha P. Mims, Anna Frolov, Effie Rahman, Gustavo A. Rivero, MD
Journal: Blood
Blood (2014) 124 (21): 5621.
https://doi.org/10.1182/blood.V124.21.5621.5621
Published: 2014
Journal Articles

Sustained Erythroid Response Associated With Red Cell Transfusion and Progressive Growth Factor Independence Is Feasible With Adjuvant Sertraline In Low-Risk Myelodysplastic Syndrome (LR-MDS)

Rui Li, MD, PhD, Matthew Zheng, Sarvari Venkata Yellapragada, MD, Ruben Hernandez Perez, Martha Mims, MD, Gustavo A. Rivero, MD
Journal: Blood
Blood (2013) 122 (21): 5235.
https://doi.org/10.1182/blood.V122.21.5235.5235
Published: 2013
Journal Articles

Selective-Serotonin-Reuptake-Inhibitors (SSRIs) In Combination With Myeloma Directed Therapy Accelerates Sentinel M-Protein Normalization In De-Novo Multiple Myeloma

Mathew Zheng, Sarvari Venkata Yellapragada, MD, Martha Mims, MD, Ruben Hernandez Perez, Gustavo A. Rivero, MD
Journal: Blood
Blood (2013) 122 (21): 5387.
https://doi.org/10.1182/blood.V122.21.5387.5387
Published: 2013
Journal Articles

Significant Improvement in Overall Survival Among Patients Diagnosed with Low-Risk Myelodysplastic Syndrome (MDS) Treated with Selective-Serotonin-Reuptake-Inhibitors (SSRIs)

Ang Li, Sarvari Venkata Yellapragada, MD, Martha Mims, MD, Gustavo A. Rivero, MD
Journal: Blood
Blood (2012) 120 (21): 3818.
https://doi.org/10.1182/blood.V120.21.3818.3818
Published: 2012
Journal Articles

Use of SSRIs Not Associated with Increased Bleeding Events in Children: An Analysis of the Michigan Medicaid Database from 2000–2003

Kerry K Powell, MD, Wei Wang, MS, MAS, Kelly J Kelleher, MD, MPH, Sarah H O’Brien, MD, MSc
Journal: Blood
Blood (2008) 112 (11): 2389.
https://doi.org/10.1182/blood.V112.11.2389.2389
Published: 2008